These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 791721

  • 61. Receptors for peptide hormones. New insights into the pathophysiology of disease states in man.
    Kahn CR, Megyesi K, Bar RS, Eastman RC, Flier JS.
    Ann Intern Med; 1977 Feb; 86(2):205-19. PubMed ID: 189659
    [Abstract] [Full Text] [Related]

  • 62. Parathormone receptor binding and the influence of membrane degradation of the hormone.
    Juppner H, Hesch RD.
    J Immunoassay; 1980 Feb; 1(1):39-55. PubMed ID: 6262383
    [Abstract] [Full Text] [Related]

  • 63. Effect of fasting and streptozotocin in the obese-hyperglycemic (ob/ob) mouse. Apparent lack of a direct relationship between insulin binding and insulin effects.
    Le Marchand Y, Loten EG, Assimacopoulos-Jeannet F, Forgue ME, Freychet P, Jeanrenaud B.
    Diabetes; 1977 Jun; 26(6):582-90. PubMed ID: 140828
    [Abstract] [Full Text] [Related]

  • 64. The influence of cell surface receptor clustering on the thermodynamics of ligand binding and the kinetics of its dissociation.
    DeLisi C, Chabay R.
    Cell Biophys; 1979 Jun; 1(2):117-31. PubMed ID: 95172
    [Abstract] [Full Text] [Related]

  • 65. Insulin binding monitored by fluorescence correlation spectroscopy.
    Zhong ZH, Pramanik A, Ekberg K, Jansson OT, Jörnvall H, Wahren J, Rigler R.
    Diabetologia; 2001 Sep; 44(9):1184-8. PubMed ID: 11596675
    [Abstract] [Full Text] [Related]

  • 66. Insulin receptors in human endothelial cells: identification and characterization.
    Bar RS, Hoak JC, Peacock ML.
    J Clin Endocrinol Metab; 1978 Sep; 47(3):699-702. PubMed ID: 400730
    [Abstract] [Full Text] [Related]

  • 67. Receptor binding and effects of insulin and NSILA-S on glucose transport and metabolism in adipocytes from hypophysectomized rats.
    Schoenle E, Zapf J, Froesch ER.
    Diabetologia; 1979 Jan; 16(1):41-6. PubMed ID: 761737
    [Abstract] [Full Text] [Related]

  • 68. Insulin and non-suppressible insulin-like activity (NSILA-s): evidence for separate plasma membrane receptor sites.
    Megyesi K, Kahn CR, Roth J, Froesch ER, Humbel RE, Zapf J, Neville DM.
    Biochem Biophys Res Commun; 1974 Mar 15; 57(1):307-15. PubMed ID: 4364007
    [No Abstract] [Full Text] [Related]

  • 69. Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effect.
    Kenakin T.
    ACS Chem Biol; 2009 Apr 17; 4(4):249-60. PubMed ID: 19193052
    [Abstract] [Full Text] [Related]

  • 70. Characteristics of binding of a low affinity, noncooperative insulin [( LeuB25]insulin) to IM-9 lymphocytes.
    Green A, Frank BH, Rubenstein A, Tager H, Olefsky JM.
    Endocrinology; 1983 Dec 17; 113(6):1963-71. PubMed ID: 6357764
    [Abstract] [Full Text] [Related]

  • 71. Lack of a simple relationship between endogenous growth hormone and NSILA-s related peptides.
    Megyesi K, Gorden P, Kahn R.
    J Clin Endocrinol Metab; 1977 Aug 17; 45(2):330-8. PubMed ID: 885996
    [No Abstract] [Full Text] [Related]

  • 72. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo.
    Kaufmann U, Zapf J, Torretti B, Froesch ER.
    J Clin Endocrinol Metab; 1977 Jan 17; 44(1):160-6. PubMed ID: 833254
    [Abstract] [Full Text] [Related]

  • 73. Degradation, receptor binding affinity, and potency of insulin from the Atlantic hagfish (Myxine glutinosa) determined in isolated rat fat cells.
    Gammeltoft S, Gliemann J.
    J Biol Chem; 1977 Jan 25; 252(2):602-8. PubMed ID: 556725
    [Abstract] [Full Text] [Related]

  • 74. Internalization and degradation of glucagon by human mononuclear cells.
    Neal GW, Solomon SS, Duckworth WC.
    Horm Metab Res; 1986 Aug 25; 18(8):540-5. PubMed ID: 3019856
    [Abstract] [Full Text] [Related]

  • 75. Multiple receptor populations: binding isotherms and their numerical analysis.
    Pliska V.
    J Recept Signal Transduct Res; 1995 Aug 25; 15(1-4):651-75. PubMed ID: 8903971
    [Abstract] [Full Text] [Related]

  • 76. Regulation of insulin receptors in normal and abnormal physiology in humans.
    Bar RS, Harrison LC, Muggeo M, Gorden P, Kahn CR, Roth J.
    Adv Intern Med; 1979 Aug 25; 24():23-52. PubMed ID: 218432
    [Abstract] [Full Text] [Related]

  • 77. Improved insulin receptor assay: effects of an antidiabetic sulphonylurea on liver membrane insulin receptors from obese hyperglycaemic mice.
    Greenstein BD.
    Br J Pharmacol; 1979 Jun 25; 66(2):317-22. PubMed ID: 465886
    [Abstract] [Full Text] [Related]

  • 78. Insulin receptors convert to a higher affinity state subsequent to hormone binding. A two-state model for the insulin receptor.
    Corin RE, Donner DB.
    J Biol Chem; 1982 Jan 10; 257(1):104-10. PubMed ID: 7031059
    [Abstract] [Full Text] [Related]

  • 79. REgulation of insulin binding to isolated hepatocytes: correction for bound hormone fragments linearizes Scatchard plots.
    Donner DB.
    Proc Natl Acad Sci U S A; 1980 Jun 10; 77(6):3176-80. PubMed ID: 6997871
    [Abstract] [Full Text] [Related]

  • 80. Defect in cooperativity in insulin receptors from a patient with a congenital form of extreme insulin resistance.
    Taylor SI, Leventhal S.
    J Clin Invest; 1983 Jun 10; 71(6):1676-85. PubMed ID: 6345588
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.